Goldman Sachs to Pay $500M in 1MDB Shareholder Fraud Settlement 
Ferrari Luce: How Ferrari Evolved From Hybrid Supercars to Its First Fully Electric Vehicle 
Elon Musk Explores Possible Tesla-SpaceX Merger Amid Growing AI Investments 
Marvell Stock Rises After Record Q1 FY2027 Earnings Fueled by AI Demand 
Dollar Slips as Iran Peace Hopes Ease Rate Hike Fears 
Australia Urged to Simplify Regulations to Revive IPO Market and Boost Innovation 
U.S.-Iran Talks May Take Days as Oil Prices React to Strait of Hormuz Tensions 
UK Grocery Inflation Slows to 3.1% as Supermarket Price Pressures Ease in May 2026 
Samsung Workers Approve Wage Deal, Avoiding Major Strike and Boosting Chip Supply Confidence 
EU Antitrust Probe Could Lead to Massive Google Fine Under DMA Rules 
ASX Shares Plunge as Rising Tech Upgrade Costs Shake Investor Confidence 
S&P 500 Hits Record High as Tech Rally Slows Amid Iran Peace Uncertainty 
Huawei Chip Breakthrough Sparks Rally in Chinese Semiconductor Stocks 
Samsung Union Dispute Escalates Over Semiconductor Bonus Vote 
SQM Q1 Profit More Than Doubles as Lithium Prices Surge 
Asian Stocks Slip as U.S.-Iran Tensions Weigh on Markets; South Korea’s KOSPI Hits Record High 
SpaceX Starship V3 Test Flight Boosts IPO Momentum Ahead of Historic Market Debut 
CVS Health Corp., Walmart Inc., and Walgreens Boots Alliance Inc. have all agreed to settle their opioid lawsuit in the United States. It was reported that the three companies have tentatively concurred to pay a collective amount of $13.8 billion.
Their agreement to the settlement is part of their effort to resolve the lawsuits filed against them by thousands of state and local governments. Sources who are familiar with the deal said that CVS Health, Walgreens, and Walmart were all accused of mishandling the sale and distribution of opioid painkillers.
According to Reuters, the proposed settlement will push CVS to pay $5 billion in 10 years, while it will be $5.7 billion for Walgreens to be paid in 15 years, and Walmart will have to shell out $3.1 billion, mostly in advance.
The spokesperson of the group that brought the companies to court was not able to immediately respond to a request for a comment on this latest development in the case. The settlement is said to be the first nationwide deal involving retail pharmacy companies.
Moreover, the settlement is part of the 3,300 lawsuits that have been slapped against the drugmakers since 2017. The plaintiffs also include state and local governments that alleged the drug manufacturers are playing down the risks of their opioid medicines used for pain. They also said that distributors and pharmacies were ignoring red flags as prescriptions were being turned into illegal trafficking.
Walmart, CVS, and Walgreens are three major pharmacies in the U.S., and if the settlement is finalized, it will put an end to the years-long legal battle over opioids. The plaintiffs claimed that the distribution of opioids resulted in a human toll and caused a nuisance to the public, and companies must pay to fix everything.
"Once effectuated, these agreements will be the first resolutions reached with pharmacy chains and will equip communities across the country with the much-needed tools to fight back against this epidemic and bring about tangible, positive change," BBC News quoted the legal team of the plaintiffs as saying in a statement.
Meanwhile, aside from CVS, Walmart, and Walgreens, smaller pharmacy brands such as Kroger Co. and Rite Aid are also said to be facing similar lawsuits, but their cases are still pending.
Photo by Marques Thomas on Unsplash
